Sven Rottenberg

University of Bern

Switzerland

Research Interests

Explore related searches

Professors in Switzerland Professors in Cancer Biology Cancer Biology professors in Switzerland

Contact this professor

LinkedIn

Google Scholar

Articles (24)

Individualized Pooled CRISPR/Cas9 Screenings Identify CDK2 as a Druggable Vulnerability in a Canine Mammary Carcinoma Patient

Year:

2025

Advancing In Vitro Tools for Oncologic Research in Cats and Dogs

Year:

2025

H2AX promotes replication fork degradation and chemosensitivity in BRCA-deficient tumours

Year:

2024

TurboID mapping reveals the exportome of secreted intrinsically disordered proteins in the transforming parasite Theileria annulata

Year:

2024

PARPi, BRCA, and gaps: controversies and future research

Year:

2024

Tumour microenvironment characterisation to stratify patients for hyperthermic intraperitoneal chemotherapy in high-grade serous ovarian cancer (OVHIPEC-1)

Year:

2024

Effective detection of <i>BRAF<sup>V595E</sup></i> mutation in canine urothelial and prostate carcinomas using immunohistochemistry

Year:

2024

Persisting cancer cells are different from bacterial persisters

Year:

2024

DNA Damage Response and Mismatch Repair Gene Defects in Advanced and Metastatic Prostate Cancer

Year:

2024

PARG-deficient tumor cells have an increased dependence on EXO1/FEN1-mediated DNA repair

Year:

2024

DNA repair, gap suppression, or fork protection: BRCA2 needs a break!

Year:

2024

International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendations

Year:

2024

Docetaxel response in BRCA1,p53-deficient mammary tumor cells is affected by Huntingtin and BAP1

Year:

2024

Chrysalis: decoding tissue compartments in spatial transcriptomics with archetypal analysis

Year:

2024

LRP6 Is a Functional Receptor for Attenuated Canine Distemper Virus

Year:

2023

Organoids of patient-derived medullary thyroid carcinoma: The first milestone towards a new in vitro model in dogs.

Year:

2023

Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers.

Year:

2022

Truncated FGFR2 is a clinically actionable oncogene in multiple cancers.

Year:

2022

Loss of the Volume-regulated Anion Channel Components LRRC8A and LRRC8D Limits Platinum Drug Efficacy

Year:

2022

A living biobank of canine mammary tumor organoids as a comparative model for human breast cancer.

Year:

2022

DNA-PKcs promotes fork reversal and chemoresistance.

Year:

2022

Towards a national strategy for digital pathology in Switzerland.

Year:

2022

Meiotic Genes and DNA Double Strand Break Repair in Cancer.

Year:

2022

Functional genetic dropout screens and <i>in vivo</i> validation of candidate therapeutic targets using mouse mammary tumoroids.

Year:

2022

Collaborators (11)

Philipp Olias

Director / Professor

Justus Liebig University

GERMANY

Lennart Opitz

ETH Zurich

SWITZERLAND

Doron Merkler

University of Geneva

SWITZERLAND

Gregory Riedlinger

Rutgers Cancer Institute of New Jersey

UNITED STATES

Nora M. Gerhards

Wageningen University & Research

NETHERLANDS

Ewa Gogola

University of Oxford

UNITED KINGDOM

Claus Sorensen

Københavns Universitet

DENMARK

Enni Markkanen

University of Zurich

SWITZERLAND

Philippe Plattet

University of Bern

SWITZERLAND

Andrea Morandi

University of Florence

ITALY

Alessandro Sartori

University of Zurich

SWITZERLAND

Social connections

How do I reach out?

Sign in for free to see their profile details and contact information.

Meet Kite AI